Cover Image
市場調查報告書

全球疫苗市場:開發平台分析

Global Vaccine Market Pipeline Analysis

出版商 PNS Pharma 商品編碼 302552
出版日期 內容資訊 英文 1550 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球疫苗市場:開發平台分析 Global Vaccine Market Pipeline Analysis
出版日期: 2014年01月14日 內容資訊: 英文 1550 Pages
簡介

疫苗市場,分類為人類用及動物用2種。人體疫苗部門可再分為兒童用、青年用、成人用及老人用的4個群組。醫藥品整體銷售額中的疫苗佔有率,為2∼3%左右非常小,不過其成長率令人驚異。醫藥品產業整體的成長率年率5∼7%,而疫苗達到10∼15%。目前全球疫苗市場,推測超過300億美元的規模。該市場今後,由於免疫學、遺傳學,及疫苗技術的進步和新興經濟人口增加伴隨的需求擴大等要素,預計2025年成長超過1000億美元的規模。

本報告提供各種疫苗的開發趨勢的詳細的調查,為您概述為以下內容。

第1章 全球疫苗市場概要

第2章 疫苗臨床開發階段:不明

  • 概要
  • 疫苗臨床階段的簡介

第3章 疫苗臨床開發階段:研究

  • 概要
  • 疫苗臨床階段的簡介

第4章 疫苗臨床開發階段:臨床試驗前

  • 概要
  • 疫苗臨床階段的簡介

第5章 疫苗臨床開發階段:臨床試驗

  • 概要
  • 疫苗臨床階段的簡介

第6章 疫苗臨床開發階段:階段0

  • 概要
  • 疫苗臨床階段的簡介

第7章 疫苗臨床開發階段:階段I

  • 概要
  • 疫苗臨床階段的簡介

第8章 疫苗臨床開發階段:階段I/II

  • 概要
  • 疫苗臨床階段的簡介

第9章 疫苗臨床開發階段:階段II

  • 概要
  • 疫苗臨床階段的簡介

第10章 疫苗臨床開發階段:階段II/III

  • 概要
  • 疫苗臨床階段的簡介

第11章 疫苗臨床開發階段:階段III

  • 概要
  • 疫苗臨床階段的簡介

第12章 疫苗臨床開發階段:預備登記

  • 概要
  • 疫苗臨床階段的簡介

第13章 疫苗臨床開發階段:登記完畢

  • 概要
  • 疫苗臨床階段的簡介

第14章 上市

  • 概要
  • 已上市疫苗簡介
目錄

The global vaccine market is characterized into human and animal vaccines. The segment of human vaccines is further sub-divided into four groups namely, pediatrics, adolescents, adults and elderly. Though the vaccines segment forms a very small portion of the global pharmaceutical drug sales(2-3%), the growth rate in this market has been extraordinary. This segment has grown at a high rate of 10-15% annually as compared to the overall pharmaceutical industry which grows at 5-7% per year.

The global market for vaccines is currently estimated to be worth more than US$ 30 Billion. with factors like advances in immunology, genetics and vaccine technology as well as increased demand from population growth in emerging economies, the global vaccine market is expected to surpass estimated USD 100 billion by 2025.

"Global Vaccine Market Pipeline Analysis" by PNS Pharma gives comprehensive insight on the various vaccines being developed across multiple indications. Research report covers all vaccines being developed in various clinical phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the global vaccines market based upon development process.

Following parameters for each drug profile in development phase are covered in "Global Vaccine Market Pipeline Analysis" research report:

  • Drug Profile Overview
  • Active Indication
  • Phase of Development
  • Country for Clinical Trial
  • Owner / Originator/ Licensee/Collaborator
  • Administrative Route
  • Drug Class
  • Patent Information
  • Molecular Formula
  • Brand Names
  • Development Agreements
  • ATC Codes

Number of Vaccines in Pipeline by Clinical Phase:

  • Research: 110
  • Preclinical: 378
  • Clinical: 15
  • Phase 0: 1
  • Phase-I: 177
  • Phase-I/II: 69
  • Phase-II: 137
  • Phase-II/III: 11
  • Phase-III: 52
  • Preregistration: 15
  • Registered: 20
  • Marketed: 156
  • Unknown: 1

Table of Contents

1. Global Vaccine Market Overview

2. Vaccine Clinical Development Phase: Unknown

  • 2.1. Overview
  • 2.2. Vaccine Profile in Clinical Phase

3. Vaccine Clinical Development Phase: Research

  • 3.1. Overview
  • 3.2. Vaccine Profile in Clinical Phase

4. Vaccine Clinical Development Phase: Preclinical

  • 4.1. Overview
  • 4.2. Vaccine Profile in Clinical Phase

5. Vaccine Clinical Development Phase: Clinical

  • 5.1. Overview
  • 5.2. Vaccine Profile in Clinical Phase

6. Vaccine Clinical Development Phase: Phase-0

  • 6.1. Overview
  • 6.2. Vaccine Profile in Clinical Phase

7. Vaccine Clinical Development Phase: Phase-I

  • 7.1. Overview
  • 7.2. Vaccine Profile in Clinical Phase

8. Vaccine Clinical Development Phase: Phase-I/II

  • 8.1. Overview
  • 8.2. Vaccine Profile in Clinical Phase

9. Vaccine Clinical Development Phase: Phase-II

  • 9.1. Overview
  • 9.2. Vaccine Profile in Clinical Phase

10. Vaccine Clinical Development Phase: Phase-II/III

  • 10.1. Overview
  • 10.2. Vaccine Profile in Clinical Phase

11. Vaccine Clinical Development Phase: Phase-III

  • 11.1. Overview
  • 11.2. Vaccine Profile in Clinical Phase

12. Vaccine Clinical Development Phase: Preregistration

  • 12.1. Overview
  • 12.2. Vaccine Profile in Clinical Phase

13. Vaccine Clinical Development Phase: Registered

  • 13.1. Overview
  • 13.2. Vaccine Profile in Clinical Phase

14. Marketed

  • 14.1. Overview
  • 14.2. Vaccine Profile in Market

List of Table

Each Drug Profile has Tables Representing Following Information:

  • Alternate Names
  • Originator & Owner
  • Collaborator
  • Technology Provider
  • Licensee
  • Highest Development Phase
  • Indications
  • Class
  • Mechanism of Action
  • ATC Code
  • Designated Brand Name
Back to Top